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INTRODUCTION
Extrahepatic portal obstruction (EHO) is a disease
including an obstruction of the porta hepatis, and
shows portal hypertension. EHO occurs most often
in infants, and the cause in most patients is reported
to be pylethrombosis (1). Adult EHO is often caused
by hepatic cirrhosis, idiopathic portal hypertension,
tumor embolism, conditions derived fromaceliotomy,
and pyogenic pylephlebitis followed by abdominal
inflammation, such as cholecystitis and appendicitis
(2). However, adult EHO, for which apparent causal
diseases cannot be clinically identified andwhich shows
abnormalities in liver function but is not accompanied
by portal hypertension symptoms, is rare, and its di-
agnosis as well as distinguishing it from a malignant
hepatic tumor is not always easy.
CASE REPORT
The patient, a 51-year-old Japanesemale, consulted
a local physician because he had had fever and epi-
gastralgia. Abdominal ultrasonography demonstrated
a hyperechoic lesion occupying the left portal vein,
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and the patient was admitted to our hospital for close
examination and treatment one month later.
The patient had a mild fever but neither anemia nor
jaundice, and the abdomenwas flat and soft without ten-
derness. The results of a biochemical examination at
the time of admissionwere as follows :WBC11,860/mm3
andCRP10.8mg/dl l (normal range, <0.3mg/dl), show-
ing increased inflammatory reactions, and aspartate
aminotransferase 72 U/l (normal range, 8-38 U/l),
alanine aminotransferase 126 U/l (normal range, 8-
40 U/l), lactate dehydrogenase 576 U/l (normal range,
220-450 U/l), and gamma-glutamyl transpeptidase
91 U/l (normal range, 0-60 U/l), indicative of abnor-
malities in liver function. In the coagulation system,
the prothrombin time was 11.3 sec (normal range,
11-15 sec) and the active thromboplastin time 29.5 sec
(normal range, 23-36 sec), showing no abnormalities.
The number of thrombocytes was 21.9×104/ mm3,
total bilirubin 0.6mg/dl (normal range, 0.2-1.2mg/dl),
alkaline phosphatase 340 U/l (normal range, 250-380
U/l), and hemoglobin 15.3 g/dl, all of which were
within the normal range. Viral markers, such as the
hepatitis C virus antibody, hepatitis B surface antigen,
and hepatitis B core antibody,werenegative, and tumor
markers, such as alpha-fetoprotein, carbohydrate antigen
19-9, and carcinoembryonic antigen, were also nega-
tive. Abdominal ultrasonography demonstrated a hy-
perechoic lesion occupying the left portal vein (Fig. 1),
and abdominal plain CT showed that the lesion had
a low density with a clear boundary,measuring about
3 cm× 2 cm, between the porta hepatis and segment
IV of the liver. Contrast CT showed no enhancement
in the arterial and portal phases, but reduction of the
density inside the tumor in the equilibration phase
was noted (Fig. 2). Abdominal MRI demonstrated
a node with a diameter of about 2 cm around liver seg-
ment IV showing hypointensity by T1-weighted imaging
and hyperintensity by T2-weighted imaging (Fig. 3).
Splenomegaly was not detected by the imagingmeth-
ods, nor were abnormalities in theesophagusand stom-
ach, including varices observed by endoscopy of the
upper digestive tract. No abnormalities, such as tumor
enhancement, were observed by angiography of the
common hepatic artery, but the left portal branch and
superior mesenteric vein were not enhanced by por-
tography via the superior mesenteric vein (Fig. 4).
Endoscopic retrograde cholangiography (ERC) using
a balloon catheter revealed a local constriction at the
starting point of the left intrahepatic bile duct (Fig. 5).
At that point, considering that the elevation of theCRP,
fever and alteration of liver function as well as epi-
gastralgia might be caused by a cholangitis, intra-
venous injection of antibiotics and parenteral nutri-
tion in a fasting state were administered. Thereaf-
ter, the presenting symptoms such as fever and epi-
gastralgia remitted, and inflammatory responses nor-
malized. Liver function tests indicated gradual im-
Fig. 1. Abdominal ultrasonography
A hyperechoic lesion occupying the left portal vein was observed
(arrow).
Fig. 2. Dynamic computed tomography of the liver
A low density lesion (about 3 cm × 2 cm in size) (arrow head) was observed between the porta hepatis and
segment IV of the liver. No enhancement was detected (A), but a low density was observed in the equilibration
phase at the center inside the tumor (arrow head) (B).
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provement, but not normalization.
Since the possibility of intrahepatic cholangiocar-
cinoma could not be excluded basedon these findings,
extended left hepatectomy combined with caudate
lobectomy was performed 35 days after admission.
The size of the tumorwas 31mm×21mm×20mm.
What appeared to be a tumorwas, in fact, an increased
portal area, and proliferation of connective tissues was
observed around the starting point of the obstructed
left portal vein (Fig. 6). Although portal vein pressure
was not measured, findings derived from portal hy-
pertension such as the development of collateral cir-
culation and splenomegaly were not observed. Patho-
histologically, no malignancy was detected. Prolif-
eration of bile duct and periductal fibrosis around the
portal area was noted with chronic inflammation, and
old thrombi that had obstructed the left portal vein
were scattered, showing chronic cholangitis andportal
thrombosis, respectively (Fig. 7). Neither infiltration
by inflammatory cells nor theproliferationof fibroblasts
nor capillary vascularization was observed.
Based on these findings, the patient was diagnosed
as having EHO. The postoperative course was satis-
factory. All results of biochemical blood examinations
were normal. As of about 5 years after surgery, no sign
of recurrence was observed.
Fig. 3. Magnetic resonance imaging of the liver
A node showing hypointensity (arrow head) by T1-weighted imaging (A) and hyperintensity (arrow head) by
T 2-weighted imaging (B) was observed around the liver segment IV.
Fig. 4. Portography via the superior mesenteric vein
The left portal branch (arrow) and superior mesenteric vein (arrow
head) were not enhanced.
Fig. 5. Endoscopic retrograde cholangiography
A focal stenosis was noted at the origin of the left intrahepatic
bile duct (arrow).
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DISCUSSION
Acquired EHO is caused by tumor embolism, pyo-
genic pylephlebitis, and pylethrombosis. Pyogenic pyle-
phlebitis and pylethrombosis are frequently caused
in infants as the result of an infection in the umbilical
vein. In adults, it has been reported thatEHOis caused
by inflammatory diseases in the abdominal and pelvic
cavity, such as cholecystitis, choledochitis, pancreatitis,
and appendicitis (1,2). However, EHO patients who
had no clearly evident causal infection are often ob-
served. In the patient in this study, epigastralgia, en-
hanced inflammatory responses and abnormalities of
liver function test were observed despite the normal
value of the bilirubin in the first examination.The symp-
toms observed at the time of admission led to consider
as a cholangitis. However, these initial findings cannot
be the cause of EHO, because the thrombus obstruct-
ing the portal vein had not been formed recently. The
occlusions of the left portal vein and superior mesen-
teric vein might be derived from a pyogenic pylephle-
bitis followed by chronic cholangitis. In the acute EHO
stage, a gas image is observed in the portal vein (3),
and in the chronic stage, portal hypertension and he-
patopetal collateral vessel formation caused by an ob-
struction of the major portal vein are often observed,
particularly, cavernous transformation of the portal
vein (CTPV) around the bile duct in the porta hepatis.1
However, neither a gas image of the portal vein nor
CTPV was detected in our patient.
The diagnosis of EHO is clinicallymade on thebasis
of history of upper gastrointestinal bleeding, near-
normal liver functions, and evidence of portal hyper-
tension and obstruction in the extrahepatic portal vein
(1, 4). Thus, histological confirmation shouldbeoriented
to the definition of portal or periportal fibrosis as was
observed in our patient. In brief, the architectural
patternof the liver isreservedinEHO.There isconcentric
condensation of reticulin fibers around portal tracts.
Such periportal fibrosis could arise from nonspecific,
or specific inflammation, extension of the extrahepatic
thrombophlebitic process into the intrahepatic radicals
of the portal vein, or chemical irritation as a result of
hepatocellular breakdown products or bile imbibition
(1). The most common site of portal obstruction is
at the portal trunk, and often the entire length of the
portal vein is occluded with extension into the splenic
vein andsometimes into theupperportionof the superior
mesenteric vein (1). Obstruction of the porta hepatis
and portal trunk results in portal hypertension and
is a common cause of upper gastrointestinal bleeding
and CTPV. In our patient, however, the detected ob-
struction site was at the superior mesenteric vein and
left portal branch, whichmight be a reason not to lead
to portal hypertension. The segmental obstruction in-
volving the splenic or mesenteric vein is infrequent
Fig. 6. The cut surface of the tumor in the excised liver specimen
The tumor, measuring 31mm× 21mm× 20mm, was a milk-white
solid tumor with a clear boundary.
Fig. 7. Microscopic view of the hepatic mass
(A)Most of the portal veins within themasswere occludedby fibrous
connective tissue without recanalization, and were surrounded by
concentric collagenous connective tissue. The wall of the occluded
portal vein did not show any inflammatory or destructive changes
(HE stain, × 40). (B) Theportal vein is occludedby fibrous connective
tissue. The architecture of the venous wall is preserved. The vein
is surrounded by dense collagenous connective tissue (Victoria blue
& HE stain, × 200).
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(5). Ogawa et al. reported that EHOwith intrahepatic
obstruction of the portal branch tended to predomi-
nate (6).
The incidence of EHO is high in India and Southeast
Asian countries (7,8). Studies of portal hypertension
in Japanese patients with EHO using a questionnaire
indicated that esophageal varices and splenomegaly,
respectively, were observed in 89% and 70% of the pa-
tients (9), and that liver dysfunction wasmild (10). Fur-
thermore, abnormalities in coagulability were often ob-
served, and a prolongation of prothrombin time and a
decrease in thrombocytes have been reported (7,8,11).
In our patient, esophageal varices, splenomegaly, and
abnormalities in coagulability were not detected, but
sustained liver dysfunctionwas observed. The CT and
MRI findings showed a grossly resemblance to those
of intrahepatic cholangiocarcinoma. The obstruction
of the left portal vein, observed by abdominal angiog-
raphy, and a constriction in the left intrahepatic bile
duct, observed by ERC, also gave themisleading pos-
sibility of tumor embolism or invasion. Although the
standard surgical treatmentofEHOwasportosystemic
shunts, the patient in this study has been left untreated
after liver resection, because no symptomatic portal
biliopathy and hypersplenism including variceal bleed-
ing were observed thereafter. In EHO, the secondary
exclusion of the intrahepatic bile duct caused by the
proliferationof connective tissues around theobstructed
portal vein sometimes shows a constriction in the bile
duct, as was observed in our patient. Bayraktar et al.
reported that a partial obstruction extending along
the length of the commonbile duct was found in EHO,
which was referred to aspseudo-cholangiocarcinoma
(12). In some patients, an esophageal varix is formed
and ruptured in the bile lumen, in which conditions
similar to primary sclerosing cholangitis are observed
by cholangiography (13). It is necessary to consider
adult EHO, as observed in our patient, as a disease to
be distinguished from intrahepatic tumor lesions.
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